• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经胸食管切除术治疗食管鳞状细胞癌。

Transhiatal esophagectomy for squamous cell carcinoma of the esophagus.

作者信息

Dudhat S B, Shinde S R

机构信息

Department of Surgery, Tata Memorial Hospital, Parel, Mumbai, India.

出版信息

Dis Esophagus. 1998 Oct;11(4):226-30. doi: 10.1093/dote/11.4.226.

DOI:10.1093/dote/11.4.226
PMID:10071803
Abstract

Eighty patients underwent transhiatal esophagectomy for squamous cell carcinoma of the esophagus. Dysphagia for solids was the presenting symptom in 90% of the patients. The standard technique of transhiatal esophagectomy was used and cervical anastomosis were hand sewn. The average operative time and blood loss were 190 min and 350 cc respectively. The 30 day mortality rate was 7.5% (six patients). Major respiratory complications were observed in 15 (18.7%) patients. Anastomotic leak rate was 10% (eight patients). The incidence of recurrent laryngeal nerve injury was 6.2% (five patients). The average hospital stay was 14 days. Four patients had stage I, 30 had stage II and 46 had stage III disease. Forty-nine patients (60%) had lymph node involvement. The overall actual survival at 2 years was 55% and at 5 years was 37%. Of the operative survivors, 87% patients resumed normal swallowing and 10 patients (13.5%) required dilatation for anastomotic stricture. Transhiatal esophagectomy can be performed with low operative mortality, acceptable morbidity and offers good long-term functional results without compromising the survival of patients.

摘要

80例患者因食管鳞状细胞癌接受经胸食管切除术。90%的患者以固体食物吞咽困难为首发症状。采用经胸食管切除术的标准技术,颈部吻合口采用手工缝合。平均手术时间和失血量分别为190分钟和350毫升。30天死亡率为7.5%(6例患者)。15例(18.7%)患者出现主要呼吸并发症。吻合口漏发生率为10%(8例患者)。喉返神经损伤发生率为6.2%(5例患者)。平均住院时间为14天。4例患者为I期,30例为II期,46例为III期疾病。49例患者(60%)有淋巴结受累。2年总体实际生存率为55%,5年为37%。手术存活患者中,87%恢复正常吞咽,10例患者(13.5%)因吻合口狭窄需要扩张。经胸食管切除术可在低手术死亡率、可接受的发病率下进行,并能提供良好的长期功能结果,而不影响患者的生存。

相似文献

1
Transhiatal esophagectomy for squamous cell carcinoma of the esophagus.经胸食管切除术治疗食管鳞状细胞癌。
Dis Esophagus. 1998 Oct;11(4):226-30. doi: 10.1093/dote/11.4.226.
2
Robot-assisted transhiatal esophagectomy: a 3-year single-center experience.机器人辅助经食管裂孔食管切除术:3 年单中心经验。
Dis Esophagus. 2013 Feb-Mar;26(2):159-66. doi: 10.1111/j.1442-2050.2012.01325.x. Epub 2012 Mar 6.
3
An audit of surgical outcomes of esophageal squamous cell carcinoma.食管鳞状细胞癌手术结果的审计
Eur J Cardiothorac Surg. 2007 Mar;31(3):536-44. doi: 10.1016/j.ejcts.2006.12.002. Epub 2007 Jan 11.
4
Transhiatal esophagectomy for benign and malignant disease.经胸食管切除术治疗良性和恶性疾病。
J Thorac Cardiovasc Surg. 1993 Feb;105(2):265-76; discussion 276-7.
5
Transhiatal esophageal surgery for malignancy--a 7-year experience at a tertiary care hospital.经胸食管恶性肿瘤手术——一家三级医院的7年经验
J Coll Physicians Surg Pak. 2009 Jul;19(7):413-6.
6
Minimally invasive transhiatal esophagectomy: lessons learned.微创经裂孔食管切除术:经验教训
Surg Endosc. 2007 Jul;21(7):1190-3. doi: 10.1007/s00464-007-9312-y. Epub 2007 May 4.
7
Transhiatal oesophagectomy in the management of advanced oesophageal carcinoma.经胸食管切除术在晚期食管癌治疗中的应用
J R Coll Surg Edinb. 1992 Aug;37(4):225-8.
8
Perioperative outcomes of single-port mediastinoscope-assisted transhiatal esophagectomy for thoracic esophageal cancer.单孔纵隔镜辅助经裂孔食管癌切除术治疗胸段食管癌的围手术期结果
Dis Esophagus. 2017 Oct 1;30(10):1-8. doi: 10.1093/dote/dox047.
9
A change in clinical practice: a partially stapled cervical esophagogastric anastomosis reduces morbidity and improves functional outcome after esophagectomy for cancer.临床实践中的一项改变:部分吻合器吻合的颈段食管胃吻合术可降低食管癌切除术后的发病率并改善功能结局。
Dis Esophagus. 2008;21(5):422-9. doi: 10.1111/j.1442-2050.2007.00792.x.
10
Cervical esophagogastric anastomosis: results following esophagectomy for carcinoma.颈段食管胃吻合术:食管癌切除术后的结果
Dis Esophagus. 1999;12(4):264-9. doi: 10.1046/j.1442-2050.1999.00051.x.

引用本文的文献

1
TRANSHIATAL ESOPHAGECTOMY IN SQUAMOUS CELL CARCINOMA OF THE ESOPHAGUS: WHAT ARE THE BEST INDICATIONS?经胸食管切除术治疗食管鳞癌:最佳适应证是什么?
Arq Bras Cir Dig. 2021 Mar 22;33(4):e1567. doi: 10.1590/0102-672020200004e1567. eCollection 2021.
2
Laparoscopic esophagectomy in the palliative treatment of advanced esophageal cancer after radiochemotherapy.腹腔镜食管癌切除术在放化疗后晚期食管癌姑息治疗中的应用
Surg Endosc. 2004 Dec;18(12):1789-94. doi: 10.1007/s00464-003-9243-1. Epub 2004 Oct 26.